Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate

Journal of Urology

Volumn 157, Issue 1, 1997, Pages 199-203

  Eskew, L A ^a   Bare, R L ^a   McCullough, D L ^a   Stamey, T A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

biopsy; carcinoma; diagnosis; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; HEMATURIA; HEMOSPERMIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PAIN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0031060277     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65322-9     Document Type: Article

References (14)

1. Parker S.L. Tong T. Bolden S. Wingo P.A. Cancer statistics, 1996. CA 46 1996 5
2. Catalona W.J. Smith D.S. Ratliff T.L. Basler J.W. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A. 270 1993 948
3. Hodge K.K. McNeal J.E. Terris M.K. Stamey T.A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol. 142 1989 71
4. Bare R. Hart L. McCullough D.L. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy. Urology 43 1994 191
5. Albertsen P.C. Fryback D.G. Storer B.E. Kolon T.F. Fine J. Long-term survival among men with conservatively treated localized prostate cancer. J.A.M.A. 274 1995 626
6. Aus G. Hugosson J. Norten L. Long-term survival and mortality in prostate cancer treated with noncurative intent. J. Urol. 154 1995 460
7. Guthman D.A. Wilson T.M. Blue M.L. Bergstralh E.J. Zincke H. Oesterling J.E. Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristics. Urology 42 1993 150
8. Stormont T.J. Farrow G.M. Myers R.P. Blute M.L. Zincke H. Wilson T.M. Oesterling J.E. Clinical stage BO or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration. Urology 41 1993 3
9. Scaletscky R. Koch M.O. Eckstein C.W. Bicknell S.L. Gray G.F. Jr. Smith J.A. Jr. Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen. J. Urol. 152 1994 129
10. Lerner S.E. Seay T.M. Blute M.L. Bergstralh M.S. Barrett D.M. Zincke H. PSA detected prostate cancer (clinical stage T1c): an interim analysis. J. Urol. 155 1996 821
11. Eskew, L. A., Bare, R. L. and McCullough, D. L.: Patient characteristics and pathological findings in men undergoing repeat biopsies for suspected prostatic carcinoma. Read at annual meeting of Southeastern Section, American Urological Association, 1995.
12. Stricker H.J. Ruddock L.J. Wan J. Belville W.D. Detection of non-palpable prostate cancer. A mathematical and laboratory model Brit. J. Urol. 71 1993 43
13. Stamey T.A. Making the most of six systematic sextant biopsies. Urology 45 1995 2
14. Selzman A.A. Resnick M.I. Transrectal ultrasound and prostate biopsy. Sem. Urol. 12 1994 265